RCC1 and lung carcinoma: Previous studies showed that human lung cancer cell lines treated with metformin (10–40 mM) do undergo anti-neoplastic effects, evidenced by repressing cell growth and cell cycle regulatory proteins, namely p27, p57, and PTEN [37].